Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration.

The wobbler mouse is a model of selective motor neuron degeneration in the cervical spinal cord. Comparing cervical and lumbar tracts of control and diseased mice at the early stage of pathology by proteomic analysis, we identified 31 proteins by peptide mass fingerprint after tryptic digestion and MALDI-TOF analysis, that were differently represented among the four experimental groups. In healthy mice, patterns of protein expression differed between cervical and lumbar tract: proteins of cellular energetic metabolism pathway showed lower expression in the cervical tract, while cellular trafficking proteins were overrepresented. In wobbler mice, these differences disappeared and the expression pattern was similar between cervical and lumbar spinal cord. We found that most of the proteins differentially regulated in wobbler with respect to control cervical tract were related to astrogliosis or involved in glutamate-glutamine cycle, energy transduction and redox functions. Proteins overrepresented in the wobbler lumbar spinal cord were cytoskeleton proteins and cellular transport proteins, in particular the vesicle fusing ATPase and the isoform 2 of syntaxin-binding protein 1, involved in vesicle trafficking. We suggest that overexpression of proteins involved in vesicle trafficking, together with proteins counteracting mitochondrial dysfunction can have neuroprotective effects, preserving lumbar spinal cord motor neurons in wobbler mice.

[1]  Haining Zhu,et al.  Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord , 2009, The FEBS journal.

[2]  P. Andersen,et al.  Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis* , 2009, Molecular & Cellular Proteomics.

[3]  K. Talbot,et al.  Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS , 2008, Progress in Neurobiology.

[4]  M. Repici,et al.  Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse , 2008, Neurobiology of Disease.

[5]  S. Ennis,et al.  Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[6]  C. Cereda,et al.  2‐DE and MALDI‐TOF‐MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis , 2007, Electrophoresis.

[7]  Adriano Chiò,et al.  The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. , 2007, Current medicinal chemistry.

[8]  M. Salmona,et al.  Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. , 2007, Biochemical and biophysical research communications.

[9]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[10]  T. Siddique,et al.  Informatics-assisted Protein Profiling in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis*S , 2006, Molecular & Cellular Proteomics.

[11]  K. Morrison,et al.  Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment , 2006, Expert Reviews in Molecular Medicine.

[12]  A. Lengeling,et al.  Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse , 2005, Nature Genetics.

[13]  R. Schwarzenbacher,et al.  Characterization of the human GARP (Golgi associated retrograde protein) complex. , 2005, Experimental cell research.

[14]  M. Salmona,et al.  Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2005, Journal of Biological Chemistry.

[15]  D. Butterfield,et al.  Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.

[16]  D. Pollak,et al.  Cerebellar protein expression in three different mouse strains and their relevance for motor performance , 2005, Neurochemistry International.

[17]  J. H. Boo,et al.  Profiling proteins related to amyloid deposited brain of Tg2576 mice , 2004, Proteomics.

[18]  M. Biggiogera,et al.  Evidence for chronic mitochondrial impairment in the cervical spinal cord of a murine model of motor neuron disease , 2004, Neurobiology of Disease.

[19]  D. Pollak,et al.  Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. , 2004, Free radical biology & medicine.

[20]  C. Bendotti,et al.  Lessons from models of SOD1-linked familial ALS. , 2004, Trends in molecular medicine.

[21]  M. Peschanski,et al.  The wobbler mouse , 2003, Molecular Neurobiology.

[22]  F. Menzies,et al.  Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways* , 2003, The Journal of Biological Chemistry.

[23]  P. Guarneri,et al.  Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system , 2002, The European journal of neuroscience.

[24]  Aidong Yuan,et al.  Slow axonal transport of the cytosolic chaperonin CCT with Hsc73 and actin in motor neurons , 2002, Journal of neuroscience research.

[25]  P. Shaw,et al.  Glutamine synthetase activity and expression are not affected by the development of motor neuronopathy in the G93A SOD-1/ALS mouse. , 2001, Brain research. Molecular brain research.

[26]  P. Bigini,et al.  Glutamate transporters in the spinal cord of the wobbler mouse , 2001, Neuroreport.

[27]  K. Kang,et al.  Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1* , 2001, The Journal of Biological Chemistry.

[28]  M. Ferrini,et al.  In Vitro Differences Between Astrocytes of Control and Wobbler Mice Spinal Cord , 1999, Neurochemical Research.

[29]  H. Jockusch,et al.  Spatiotemporal progression of neurodegeneration and glia activation in the wobbler neuropathy of the mouse. , 1999, Neuroreport.

[30]  J. Pevsner,et al.  Regulation of Munc-18/Syntaxin 1A Interaction by Cyclin-dependent Kinase 5 in Nerve Endings* , 1998, The Journal of Biological Chemistry.

[31]  P. Parvy,et al.  Excess Extracellular and Low Intracellular Glutamate in Poorly Differentiating Wobbler Astrocytes and Astrocyte Recovery in Glutamine‐Depleted Culture Medium , 1995, Journal of neurochemistry.

[32]  F. Rieger,et al.  Astrocytosis in wobbler mouse spinal cord involves a population of astrocytes which is glutamine synthetase-negative , 1995, Neuroscience Letters.

[33]  F. Rieger,et al.  Abnormal astrocyte differentiation and defective cellular interactions in wobbler mouse spinal cord , 1994, Journal of neurocytology.

[34]  K. Gengyo-Ando,et al.  The C. elegans unc-18 gene encodes a protein expressed in motor neurons , 1993, Neuron.

[35]  I. Mcquarrie,et al.  Retardation of fast axonal transport in wobbler mice , 1993, Muscle & nerve.

[36]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[37]  H. Mitsumoto,et al.  Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron. , 1982, Brain : a journal of neurology.

[38]  S. Strich,et al.  An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. , 1968, Journal of neurology, neurosurgery, and psychiatry.

[39]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[40]  M. Staufenbiel,et al.  Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypes. , 2008, Journal of Alzheimer's disease : JAD.

[41]  D. Butterfield,et al.  Proteomics analysis of the Alzheimer's disease hippocampal proteome. , 2007, Journal of Alzheimer's disease : JAD.

[42]  D. Butterfield,et al.  Original Contribution Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice—A model of familial amyotrophic lateral sclerosis , 2005 .

[43]  P. Bigini,et al.  Immunohistochemical localization of TNFalpha and its receptors in the rodent central nervous system. , 2004, Methods in molecular medicine.

[44]  D. Pappin.  Peptide mass fingerprinting using MALDI-TOF mass spectrometry. , 2003, Methods in molecular biology.

[45]  Robert G. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2007, The Cochrane database of systematic reviews.

[46]  P. S. Sillevis Smitt,et al.  Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies , 1989, Journal of the Neurological Sciences.